Literature DB >> 8345361

Subgenomic RNAs of Lelystad virus contain a conserved leader-body junction sequence.

J J Meulenberg1, E J de Meijer, R J Moormann.   

Abstract

During the replication of Lelystad virus in alveolar lung macrophages, a 3'-coterminal nested set of six subgenomic RNAs (RNA2 to RNA7) is formed. These contain a common leader sequence derived from the 5' non-coding region of the genomic RNA. In this study, the sequence of the junction sites, i.e. the sites where the leader sequence joins to the body of the subgenomic RNA, was determined for all six subgenomic RNAs. For each subgenomic RNA, six to nine cDNA clones were isolated by means of reverse transcription and PCR. The nucleotide sequence at the junction site was identical for all eight cDNA clones derived from subgenomic RNA4. However, heterogeneity was observed in the nucleotide sequence surrounding the junction sites of the cDNA clones derived from subgenomic RNAs 2, 3, 5, 6 and 7. This heterogeneity suggests that the fusion of the leader to the body of the subgenomic RNA may be imprecise. The junction sites of the six subgenomic RNAs had a conserved sequence motif of six nucleotides (UCAACC or a highly similar sequence). The distance between the junction site and the translation initiation codon of the downstream open reading frame varied from nine to 83 nucleotides.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8345361     DOI: 10.1099/0022-1317-74-8-1697

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  58 in total

1.  Posttranslational processing and identification of a neutralization domain of the GP4 protein encoded by ORF4 of Lelystad virus.

Authors:  J J Meulenberg; A P van Nieuwstadt; A van Essen-Zandbergen; J P Langeveld
Journal:  J Virol       Date:  1997-08       Impact factor: 5.103

2.  Genetic manipulation of arterivirus alternative mRNA leader-body junction sites reveals tight regulation of structural protein expression.

Authors:  A O Pasternak; A P Gultyaev; W J Spaan; E J Snijder
Journal:  J Virol       Date:  2000-12       Impact factor: 5.103

3.  Regulation of relative abundance of arterivirus subgenomic mRNAs.

Authors:  Alexander O Pasternak; Willy J M Spaan; Eric J Snijder
Journal:  J Virol       Date:  2004-08       Impact factor: 5.103

4.  Secondary structure and function of the 5'-proximal region of the equine arteritis virus RNA genome.

Authors:  Erwin Van Den Born; Alexander P Gultyaev; Eric J Snijder
Journal:  RNA       Date:  2004-03       Impact factor: 4.942

5.  Sequence analysis of the NSP2, ORF5, and ORF7 genes of 11 PRRS virus isolates from China.

Authors:  Jida Li; Yanbo Yin; Baoqing Guo; Shun Zhou; Yi Zhang; Xingcai Liu; Tingting Sun
Journal:  Virus Genes       Date:  2012-05-30       Impact factor: 2.332

6.  Suppression of porcine reproductive and respiratory syndrome virus replication in MARC-145 cells by shRNA targeting ORF1 region.

Authors:  Guanming Li; Juan Huang; Ping Jiang; Yufeng Li; Wenming Jiang; Xianwei Wang
Journal:  Virus Genes       Date:  2007-08-02       Impact factor: 2.332

7.  A 68-nucleotide sequence within the 3' noncoding region of simian hemorrhagic fever virus negative-strand RNA binds to four MA104 cell proteins.

Authors:  Y K Hwang; M A Brinton
Journal:  J Virol       Date:  1998-05       Impact factor: 5.103

8.  Subgenomic RNA synthesis directed by a synthetic defective interfering RNA of mouse hepatitis virus: a study of coronavirus transcription initiation.

Authors:  R G van der Most; R J de Groot; W J Spaan
Journal:  J Virol       Date:  1994-06       Impact factor: 5.103

9.  Porcine reproductive and respiratory syndrome virus Nsp1β inhibits interferon-activated JAK/STAT signal transduction by inducing karyopherin-α1 degradation.

Authors:  Rong Wang; Yuchen Nan; Ying Yu; Yan-Jin Zhang
Journal:  J Virol       Date:  2013-02-28       Impact factor: 5.103

10.  Porcine reproductive and respiratory syndrome virus comparison: divergent evolution on two continents.

Authors:  C J Nelsen; M P Murtaugh; K S Faaberg
Journal:  J Virol       Date:  1999-01       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.